Trials / Completed
CompletedNCT00296738
123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation
Quantitative 123I-MIBG SPECT/CT Assessment of Cardiac Sympathetic Innervation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Myocardial scintigraphy with 123I-MIBG allows for visual and semi-quantitative assessment of sympathetic cardiac innervation using the hear to mediastinum ratio (HMR). Impaired cardiac MIBG clearance may occur in patients with congestive heart failure (CHF). The purpose of present study was to develop and validate a quantitative index for the assessment of cardiac MIBG uptake kinetics using SPECT/CT for diagnosis of CHF
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SPECT/CT | GE INFINIA HAWKEYE |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2009-08-01
- Completion
- 2010-05-01
- First posted
- 2006-02-27
- Last updated
- 2011-08-18
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00296738. Inclusion in this directory is not an endorsement.